These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3946146)

  • 21. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone in the treatment of severe supraventricular tachycardias].
    Lukl J; Cernosek B; Rezácová M; Heinc P
    Vnitr Lek; 1986 Apr; 32(4):386-92. PubMed ID: 3727426
    [No Abstract]   [Full Text] [Related]  

  • 23. ["T'orsade de pointe" and amiodarone (author's transl)].
    Veglia L; Scandiffio T; Guerricchio G
    G Ital Cardiol; 1978; 8(9):1025-9. PubMed ID: 710760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone-induced polymorphous ventricular tachycardia.
    Sclarovsky S; Lewin RF; Kracoff O; Strasberg B; Arditti A; Agmon J
    Am Heart J; 1983 Jan; 105(1):6-12. PubMed ID: 6849241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
    Kuo CS; Reddy CP; Paciotti MV
    J Electrocardiol; 1985 Jan; 18(1):105-9. PubMed ID: 3882871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
    Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient)].
    Husson J
    Lille Med; 1975 Feb; 20(2):109-12. PubMed ID: 1142986
    [No Abstract]   [Full Text] [Related]  

  • 30. Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone.
    Bhandari AK; Quock C; Sung RJ
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):341-5. PubMed ID: 6204284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone.
    Somberg JC
    Am J Cardiol; 1987 Nov; 60(14):1218. PubMed ID: 3687772
    [No Abstract]   [Full Text] [Related]  

  • 35. Amiodarone. Therapeutics and guidelines.
    Frei J
    Prog Cardiovasc Nurs; 1989; 4(4):113-8. PubMed ID: 2602355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
    Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.